not that that is any surprise....to blame the threat of RS on decline of stock price is ludicrous....how about an SEC investigation....continuing plague of lawsuits and a gazillion shares......people even when these trials are complete the pool of participants is far too low to draw meaningful conclusions and even safety data.....
" Our position of strength is we have published data, and now we have additional data from subsequent patients, and follow on from the first patient that shows that we have a real proof of concept here.That is the most powerful position of strength that I can possibly think of. "
yes, this is what I'm sayin'
GR thinks the R/S topic will deflect his inadequacy at managing actc. And to the newbies, if there are any, it might work. Any baggies long over one or two weeks know better, but are hoping for the miracle that never comes, enabling them to escape actc with less than a 50-70% loss.